about
Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal modelsIdentification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemiaThe encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.Pathology dynamics predict spinal cord injury therapeutic successCalcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors.Chronic perinatal hypoxia reduces glutamate-aspartate transporter function in astrocytes through the Janus kinase/signal transducer and activator of transcription pathway.The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptorsCharacteristics of acute and chronic kainate excitotoxic damage to the optic nerve.Electrophysiological properties of NG2(+) cells: Matching physiological studies with gene expression profiles.Differentiating T2 hyperintensity in neonatal white matter by two-compartment model of diffusional kurtosis imaging.Excitotoxic damage to white matter.Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain.Vulnerability of premyelinating oligodendrocytes to white-matter damage in neonatal brain injury.Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptorsGlutamate receptor expression in multiple sclerosis lesions.Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity.Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function.Expression of glutamate transporters in rat optic nerve oligodendrocytes
P2860
Q27000069-710723FA-8217-4CD5-9206-9713C9BCEC13Q28771339-06590E46-3A5B-4065-BC6E-FCB7AFBD4F5BQ33516828-0606ED88-5AA3-493B-960C-6CDDCD1B9E40Q33805235-D68D4BCA-969C-4CBD-84A8-257A3FED87E2Q35144325-DD8A4290-2A2F-4B33-868B-FB0E4EAA4548Q35754879-37DA2A74-610C-4F85-B562-ED7F9172608BQ35858251-9B624991-E83B-4216-B496-FDAB812832DAQ36290077-1C6495E4-7D00-40DB-A2F4-50305BC26F04Q36689745-F775A368-8102-41FC-8E66-0347E1AF89F0Q36796291-B5B7DBB9-2570-4FED-8060-6CC6A2B1C5BBQ36822954-00A57F50-91FE-4A1D-BC5D-1988BFB687C4Q37253850-7BFBD61D-C198-4C67-9747-BA82745C7D87Q37405017-479AE22F-0567-4B0C-A69D-2E057F645EDCQ41453076-9BAFE964-C3FA-42CD-BE0A-E477CF6EAEE4Q41612066-E9323437-7F1E-4679-8514-788F3D922596Q46959335-D884DECD-4489-497F-BE28-90FE29859253Q48510916-ECB33A4C-53BB-41BB-8B23-8BF5BE17D568Q48588078-F27216A2-DA6E-4D45-AAF5-A36870285E9FQ57975140-874A01F8-48B2-40C8-9502-6FE87F88D041
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Pathophysiology of oligodendroglial excitotoxicity.
@en
type
label
Pathophysiology of oligodendroglial excitotoxicity.
@en
prefLabel
Pathophysiology of oligodendroglial excitotoxicity.
@en
P2093
P1476
Pathophysiology of oligodendroglial excitotoxicity.
@en
P2093
P304
P356
10.1002/(SICI)1097-4547(19961115)46:4<427::AID-JNR4>3.3.CO;2-F
P577
1996-11-01T00:00:00Z